Calamos Advisors LLC - TRANSMEDICS GROUP INC ownership

TRANSMEDICS GROUP INC's ticker is TMDX and the CUSIP is 89377M109. A total of 121 filers reported holding TRANSMEDICS GROUP INC in Q4 2021. The put-call ratio across all filers is 1.14 and the average weighting 0.1%.

Quarter-by-quarter ownership
Calamos Advisors LLC ownership history of TRANSMEDICS GROUP INC
ValueSharesWeighting
Q2 2023$5,151,585
+20.0%
61,343
+8.2%
0.02%
+19.0%
Q1 2023$4,294,195
+15.5%
56,704
-5.9%
0.02%
+23.5%
Q4 2022$3,717,519
+35.5%
60,232
-8.4%
0.02%
+30.8%
Q3 2022$2,744,000
-29.8%
65,730
-44.4%
0.01%
-23.5%
Q3 2021$3,910,000118,1410.02%
Other shareholders
TRANSMEDICS GROUP INC shareholders Q4 2021
NameSharesValueWeighting ↓
Roubaix Capital, LLC 264,438$5,027,0004.84%
Abrams Capital Management 3,499,859$66,532,0002.07%
Sandhill Capital Partners LLC 736,175$13,995,0001.55%
EMERALD ADVISERS, LLC 451,542$8,584,0000.36%
RTW INVESTMENTS, LP 503,266$9,567,0000.36%
EMERALD MUTUAL FUND ADVISERS TRUST 429,868$8,172,0000.33%
NEXT CENTURY GROWTH INVESTORS LLC 107,045$2,034,0000.26%
ELEMENT CAPITAL MANAGEMENT LLC 63,175$1,201,0000.26%
HAMILTON LANE ADVISORS LLC 19,364$368,0000.16%
Harbour Capital Advisors, LLC 20,900$397,0000.15%
View complete list of TRANSMEDICS GROUP INC shareholders